Global Sleep Aids Market Latest Update’s Report 2022Posted by sandeep gade on October 4th, 2022 The Sleep Aids Market is slated to grow on a gracious note (US$ 40.1 Bn) between 2020 and 2025. Wearable technology is bound to come up as one of the prospective solutions for ascertaining assistive healthcare services for everyone. The common applications are inclusive of managing several health conditions through wearable devices, preventive care to ICU and elderly patients, and offering quality remote care to various patients at remote areas or care homes, and likewise. This would be the conduct of Sleep Aids Market in the forecast period. The global sleep aids market is worth US$ 25.8 Bn at present, and The market for sleep aids is expected to reach US$ 40.1 Bn by 2031, while expanding at a CAGR of 4.5%. Request for a Free Sample Copy@ https://www.persistencemarketresearch.com/samples/2832 Increasing prevalence of sleep-related disorders, changing lifestyles, obesity, and increasing aging population, together with technology advancements with the launch of innovative devices are some of the factors driving demand for sleep aids. Increasing demand for sleeping pills due to modern lifestyles is one of the major factor driving demand for sleep aids. Stressful pace of life is found to be the main characteristic of modern lifestyle, thus increasing the incidence of sleep-related disorders. According to the Centers for Disease Control and Prevention (CDC) 2020 report, one-third of the U.S. population gets less than the recommended amount of sleep on a regular basis. Market Competition New product launches and acquisitions have emerged as a key growth strategy adopted by some of the leading manufacturers of sleep aids. By focusing on these strategies, key stakeholders are expanding their geographic footprints and strengthening their existing product portfolios.
For critical insights on this market, request for customization here@ https://www.persistencemarketresearch.com/request-customization/2832 Key Takeaways from Market Study
The research study is based on product (drugs {insomnia treatment drugs [doxepin hydrochloride, eszopiclone, ramelteon, triazolam, zaleplon, quazepam, and others], narcolepsy treatment drugs [modafinil, sodium oxybate, armodafinil, and others]}, devices {CPAP devices, BIPAP devices, and APAP devices}, others {mattresses & pillows, chin straps, nasal devices and mouthpieces}), by indication (insomnia, sleep deprivation, narcolepsy, sleep apnea, and others), and distribution channel (hospital pharmacies, retail pharmacies, e-Commerce, drug stores, and others), across five key regions of the world. Competitive Landscape The global market for generic sleep aids has been identified as a fairly fragmented space due to the presence of a high number of market participants. Some of the key market players included in the report are ResMed Inc., Koninklijke Philips N.V., Merck & Co. Inc., Drive DeVilbiss Healthcare LLC, GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Sanofi SA, Pfizer Inc., Eisai Co., Ltd. These are identified as key manufacturers of generic sleep aids. They are engaged in market expansion activities and the research & development of new sleep aids. Region Coverage (Regional Production, Demand & Forecast by Countries etc.): For in-depth competitive analysis, buy now@ https://www.persistencemarketresearch.com/checkout/2832 Key Questions Answered in This Report.
About Us: Persistence Market Research Contact Us: Persistence Market Research Like it? Share it!More by this author |